Business Daily from THE HINDU group of publications
Friday, Sep 19, 2008
ePaper | Mobile/PDA Version | Audio

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Overseas Investments
Get Latest Quote and Company Info
Dr Reddy’s launches subsidiary in US

Our Bureau

Hyderabad, Sept. 18 Pharma major Dr Reddy’s Laboratories Ltd has launched Promius Pharma LLC, a wholly-owned subsidiary, for specialty business in Bridgewater, US.

“The launch of Promius Pharma is a milestone in our strategy of building a sustainable and profitable branded business. We are committed to establishing a leading position in the US dermatology market,” Mr G. V. Prasad, Vice-Chairman and Chief Executive Officer, Dr Reddy’s said in a release.

The commercial launch of Promius is planned for the third quarter of this year. It would initially focus on the branded dermatology market. It already has three in-licensed and co-developed dermatological products which are scheduled to be launched in the current financial year. The portfolio comprises topical drugs for the treatment of psoriasis, and types of dermatitis.

Further, a pipeline of topical products for Promius is being developed at the integrated product development facility in Hyderabad.

“We are looking to develop a best in class company and are bringing together the most talented people from a cross section of dermatology companies. We have hired a nationally deployed sales force and are currently manufacturing commercial products,” Mr Jeffrey Wasserstein, Executive Vice-President of Dr Reddy’s (North America) and Promius Pharma said.

The Hyderabad-based company’s scrip declined 0.92 per cent at BSE on Thursday and closed at Rs 518.85.

Related Stories:
Dr Reddy's launches new drug
Dr Reddy's opens office in Nigeria
Dr Reddy's launches dermatology drug

More Stories on : Overseas Investments | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
Sundram Fasteners board appointment


Suven Life to raise $50 m
RINL staff wins awards
Arun Nanda gets top French honour
Ranbaxy hires Giuliani as advisor on USFDA move
UB Group looking to spin off subsidiaries
Lupin buys majority stake in S African pharma co
EoIs invited for titanium complex
Jai Balaji to begin work on Bengal plant by year-end
AO Smith setting up facility in Bangalore
Apollo Hospitals to build medical health records repository
Karnataka offers 1,000 acres for Nano plant
Dr Reddy’s launches subsidiary in US
Reliance submits EoI for gas supply to 6 TN cities
NTPC planning to scale up nuclear power capacity
BHPV board to be reconstituted soon
Lehman fall will not hit projects, says Bharat Infratech
BHEL targets Rs 45,000 cr turnover by 2011-12
Strides Arcolab plans domestic launch of branded drugs, nutraceuticals




Brandline



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line